Stockscreener 앱 받기
2.69
2.18%
-0.06
시간 외 거래:
2.71
0.02
+0.74%
전일 마감가:
$2.75
열려 있는:
$2.7
하루 거래량:
561.43K
Relative Volume:
0.55
시가총액:
$191.82M
수익:
-
순이익/손실:
$-192.96M
주가수익비율:
-0.8152
EPS:
-3.3
순현금흐름:
$-167.04M
1주 성능:
+12.55%
1개월 성능:
+5.91%
6개월 성능:
+110.16%
1년 성능:
+12.55%
1일 변동 폭
$2.63
$2.765
1주일 범위
$2.29
$2.96
52주 변동 폭
$0.783
$3.39
Ventyx Biosciences Inc Stock (VTYX) Company Profile
명칭
Ventyx Biosciences Inc
전화
(858) 945-2393
주소
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
VTYX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
2.69 | 196.10M | 0 | -192.96M | -167.04M | -3.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-12 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2024-03-12 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-11-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-11-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-07 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2023-11-07 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-11-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-06-14 | 재개 | Credit Suisse | Outperform |
| 2023-03-21 | 개시 | Wells Fargo | Overweight |
| 2022-12-19 | 개시 | Goldman | Buy |
| 2022-11-17 | 개시 | Morgan Stanley | Overweight |
| 2022-09-07 | 개시 | Stifel | Buy |
| 2022-09-01 | 개시 | H.C. Wainwright | Buy |
| 2022-05-09 | 개시 | Credit Suisse | Outperform |
| 2022-03-31 | 개시 | Canaccord Genuity | Buy |
| 2022-02-01 | 개시 | Oppenheimer | Outperform |
| 2021-11-15 | 개시 | Jefferies | Buy |
| 2021-11-15 | 개시 | Piper Sandler | Overweight |
모두보기
Ventyx Biosciences Inc 주식(VTYX)의 최신 뉴스
Goldman Sachs Group Inc. Has $682,000 Stock Position in Ventyx Biosciences, Inc. $VTYX - Defense World
Analyzing recovery setups for Ventyx Biosciences Inc. investorsMarket Activity Recap & Verified Entry Point Signals - newser.com
Pallas Capital Advisors LLC Acquires Shares of 17,824 Ventyx Biosciences, Inc. $VTYX - Defense World
Signal strength of Ventyx Biosciences Inc. stock in tech scannersJuly 2025 Analyst Calls & Accurate Intraday Trade Tips - newser.com
Tools to assess Ventyx Biosciences Inc.’s risk profileMarket Growth Summary & Reliable Breakout Stock Forecasts - newser.com
Risk vs reward if holding onto Ventyx Biosciences Inc.Weekly Profit Analysis & Long-Term Safe Investment Plans - newser.com
Macro Review: Can Ventyx Biosciences Inc grow without dilution2025 Pullback Review & Accurate Buy Signal Alerts - khodrobank.com
Reviewing Aprea Therapeutics (NASDAQ:APRE) and Ventyx Biosciences (NASDAQ:VTYX) - Defense World
Historical volatility pattern of Ventyx Biosciences Inc. visualized2025 Risk Factors & Reliable Breakout Forecasts - newser.com
Sentiment analysis tools applied to Ventyx Biosciences Inc.2025 Performance Recap & Real-Time Buy Signal Notifications - newser.com
Aug Catalysts: How does Ventyx Biosciences Inc. correlate with Nasdaq2025 Stock Rankings & Real-Time Volume Analysis Alerts - خودرو بانک
Using economic indicators to assess Ventyx Biosciences Inc. potential2025 AllTime Highs & Low Drawdown Investment Ideas - newser.com
Bond Watch: Can Ventyx Biosciences Inc outperform in the next rallyMarket Performance Summary & Consistent Return Strategy Ideas - خودرو بانک
Insider Sell: What are Ventyx Biosciences Incs earnings expectationsEarnings Growth Summary & Free Expert Verified Stock Movement Alerts - خودرو بانک
What earnings revisions data tells us about Ventyx Biosciences Inc.July 2025 Technicals & Free Long-Term Investment Growth Plans - newser.com
Will Ventyx Biosciences Inc. outperform the marketEarnings Recap Summary & Reliable Price Action Trade Plans - newser.com
Aug Sentiment: Should I add AREB stock to my portfolioBull Run & Safe Capital Allocation Plans - khodrobank.com
What’s the recovery path for long term holders of Ventyx Biosciences Inc.Bull Run & Free Expert Approved Momentum Trade Ideas - newser.com
Using data models to predict Ventyx Biosciences Inc. stock movement2025 Fundamental Recap & Short-Term High Return Strategies - newser.com
Forecasting Ventyx Biosciences Inc. price range with options dataEarnings Risk Report & Detailed Earnings Play Strategies - newser.com
Aug Summary: Can Ventyx Biosciences Inc scale operations efficientlyMarket Performance Recap & Verified Technical Signals - خودرو بانک
Market Review: Is Ventyx Biosciences Inc stock a buy or sell2025 Year in Review & Smart Money Movement Alerts - خودرو بانک
Take Profit: Is Ventyx Biosciences Inc stock overvalued or fairly pricedDay Trade & Expert Curated Trade Ideas - خودرو بانک
Analyst Upgrade: How does Ventyx Biosciences Inc score in quality rankingsBreakout Watch & Weekly Sector Rotation Insights - خودرو بانک
Market Fear: Is Ventyx Biosciences Inc. benefiting from interest rate changesJuly 2025 EndofMonth & Momentum Based Trading Ideas - خودرو بانک
Rate Hike: Will Ventyx Biosciences Inc stock hit new highs in YEAR2025 Technical Overview & Low Drawdown Momentum Ideas - khodrobank.com
Risks Report: Does Ventyx Biosciences Inc have consistent dividend growthMarket Risk Summary & Safe Investment Capital Preservation Plans - خودرو بانک
Movement Recap: Is WESCO International Inc a good ESG investmentWeekly Trade Summary & Long Hold Capital Preservation Tips - خودرو بانک
Aug PostEarnings: Is CSTM stock a buy or sell2025 Investor Takeaways & AI Powered Buy/Sell Recommendations - خودرو بانک
Chart Watch: What are the analyst revisions for LSTAIs Addus HomeCare Corporation stock a good investment in YEARMarket Sentiment Review & Weekly High Conviction Ideas - خودرو بانک
Ventyx Biosciences Inc. stock trend forecastWeekly Stock Analysis & Verified Chart Pattern Signals - newser.com
Ventyx Biosciences Inc (VTYX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Ventyx Biosciences Inc 주식 (VTYX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Mohan Raju | CEO AND PRESIDENT |
Mar 28 '25 |
Option Exercise |
0.00 |
11,844 |
0 |
2,303,540 |
| Nuss John | CHIEF SCIENTIFIC OFFICER |
Mar 28 '25 |
Option Exercise |
0.00 |
4,531 |
0 |
469,113 |
| Nuss John | CHIEF SCIENTIFIC OFFICER |
Dec 27 '24 |
Sale |
2.36 |
21,119 |
49,841 |
464,582 |
2.43%
자본화:
|
볼륨(24시간):